沪指4000点震荡蓄势，关注低估值“大象股”及医药股机会

Core Viewpoints - The A-share market is currently fluctuating around the 4000-point mark, reflecting cautious investor sentiment as trading volumes remain below 2 trillion yuan [1][7][10] - The market is expected to consolidate at this level, which may build a foundation for future gains, with potential for new yearly highs [1][7] - Anticipation for upcoming important meetings in December could catalyze market movements, particularly regarding economic policy adjustments aimed at growth and innovation [1][7] Market Overview - On Wednesday, the three major indices opened lower and experienced wide fluctuations, with the Shenzhen Composite and ChiNext indices both dropping over 1% [4] - The oil and gas extraction sector showed strong performance, while previously strong sectors like photovoltaic equipment faced significant corrections [4][10] - The overall market sentiment was subdued, with a total trading volume of 19,450 billion yuan, and the Shanghai Composite Index closing at 4000.14 points, down 0.07% [5][10] Sector Analysis - The pharmaceutical sector saw gains, particularly in medical commerce, medical devices, and immunotherapy stocks, indicating a potential for recovery and growth in Q4 2025 [6] - The oil and gas extraction stocks surged due to significant breakthroughs in shale oil exploration, supportive government policies, and rising international oil prices [6] Investment Strategy - A cautious approach is recommended, focusing on undervalued "elephant stocks" with high safety margins, as well as stable consumer stocks in the pharmaceutical sector [2][8] - Technology stocks with solid performance can also be considered for investment during market adjustments [2][8]